CISTRACURIUM BESYLATE
Cisatracurium Besylate is a neuromuscular blocking agent used to induce muscle relaxation during surgeries or mechanical ventilation. It acts by blocking the transmission of nerve impulses to the muscles.It is indicated for use as an adjunct to general anesthesia to facilitate tracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation.
The dosage of Cisatracurium Besylate varies depending on the patient's age, weight, and medical condition. It is typically administered intravenously and is titrated based on the patient's response.
Cisatracurium Besylate is contraindicated in patients with known hypersensitivity to the drug and in patients with a history of malignant hyperthermia.
Special precautions should be taken in patients with impaired renal or hepatic function, as well as in patients with neuromuscular diseases. Close monitoring of neuromuscular function is necessary during administration.
Common side effects of Cisatracurium Besylate include hypotension, tachycardia, bronchospasm, and prolonged muscle weakness.
Cisatracurium Besylate may potentiate the effects of other neuromuscular blocking agents and anesthetics. Caution should be exercised when administering it concurrently with other medications that affect neuromuscular function.
Brand Name | Manufactured by |
---|---|
ACRIS | GLAND PHARMA LIMITED |
CIS ACTACIL | NEON LABORATORIES LTD. |
CISATRA | THEMIS MEDICARE LIMITED |
CISBLOK | ABBOTT INDIA LTD. |
TROYCURIUM | Troikaa Pharmaceuticals Ltd |